Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?

In recent times, the plasma fractionation market has experienced significant growth. The market size is projected to escalate from $31.42 billion in 2024 to $34.14 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.6%. The historical growth can be attributed to increasing occurrences of hemophilia and immunodeficiency disorders, an aging population, heightened demand for immunoglobulins, expansion of plasma collection centers, and a surge in surgical procedures.

In the coming years, the market size for plasma fractionation is predicted to experience swift expansion, with an expected worth projecting as high as $50.54 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth over the forecast period can be tied to factors such as increased global healthcare spending, a surge in the usage of plasma-derived medications, greater investments in R&D, a heightened demand for plasma in addressing neurological conditions, and a wider dispersal of plasma fractionation facilities. The forecast period is also set to witness key trends, including the emergence of fresh fractionation technologies, a leaning towards albumin and immunoglobulin therapies, increased demand for specialty plasma products, a spotlight on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

What factors are expected to fuel Plasma Fractionation market growth in the coming years?

The plasma fractionation market is anticipated to expand due to the rising prevalence of chronic diseases. These diseases, which include heart disease, cancer, and diabetes, are illnesses that persist for a duration of one year or more, necessitating sustained medical care. The utilization of plasma products to treat patients suffering from chronic ailments not only mitigates morbidity and enhances their quality of life but also offers cost-efficiency which in turn fuels plasma fractionation demand. For example, the National Library of Medicine, a US authority, released a report in January 2023 suggesting that the count of individuals over 50 having one or more chronic diseases is anticipated to surge by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Consequently, the rising occurrence of chronic diseases is stimulating the healthcare analytical testing service market’s growth. Thus, the escalation in chronic diseases across all age groups is projected to drive the expansion of the plasma fractionation market.

What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?

The plasma fractionation market covered in this report is segmented –

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Subsegments:

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA)

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

Which Emerging Trends And Strategic Shifts Are Shaping The Plasma Fractionation Market?

Leading players in the market are adopting innovative technologies, for example, advanced facility processes that convert donated human plasma into crucial drugs, utilizing progressive technology to ensure the procedure is more safe and efficient. To exemplify, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility with an investment of $470 million which employs state-of-the-art technology towards enhancing the efficiency and safety of plasma processing. This optimizes the quality and reliability of medical products. The increased supply of these essential drugs enabled by this facility caters to the escalating demand, guaranteeing broader patient access to vital treatment options. The facility also lowers contamination risks and improves hygiene standards due to its advanced automation and self-cleaning systems, thereby increasing patient safety.

What Are The Most Active Companies In The Plasma Fractionation Market Today?

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model